Your browser doesn't support javascript.
loading
Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison.
Vadher, Karan; Patel, Hiren; Mody, Reema; Levine, Joshua A; Hoog, Meredith; Cheng, Alice Yy; Pantalone, Kevin M; Sapin, Hélène.
Afiliação
  • Vadher K; Eli Lilly and Company, Bracknell, UK.
  • Patel H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
  • Mody R; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
  • Levine JA; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
  • Hoog M; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
  • Cheng AY; Division of Endocrinology and Metabolism, Department of Medicine, Trillium Health Partners and Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada.
  • Pantalone KM; Department of Endocrinology, Cleveland Clinic, Cleveland, Ohio.
  • Sapin H; Lilly France SAS, Neuilly-sur-Seine, France.
Diabetes Obes Metab ; 24(9): 1861-1868, 2022 09.
Article em En | MEDLINE | ID: mdl-35589616
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Metformina Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Metformina Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article